Sjogrens Syndrome Measured by Ultrasound
NCT03411850 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 20
Last updated 2021-05-11
Summary
Ultrasound study focused on salivary gland outcomes in Sjogren's subjects
Conditions
- Sjogren's Syndrome
Interventions
- BIOLOGICAL
-
FDA approved biologic
- OTHER
-
Placebo
Sponsors & Collaborators
- collaborator INDUSTRY
-
Arthritis & Rheumatism Associates, P.C.
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- OTHER
- Masking
- SINGLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2016-05-31
- Primary Completion
- 2021-05-31
- Completion
- 2021-12-31
Countries
- United States
Study Locations
More Related Trials
-
An AI Algorithm for Lymphocyte Focus Score of Minor Salivary Gland Biopsy Samples for Diagnosing Sjogren's Syndrome
NCT06437652 ·Status: COMPLETED
-
Effects of Hydroxychloroquine on Oral Complaints of Sjögren Patients
NCT00873496 ·Status: COMPLETED
-
Endoscopic Treatment of Salivary Glands Affected by Sjögren's Syndrome
NCT02112019 ·Status: UNKNOWN ·Phase: NA
-
Oral Health Needs Assessment of Sjogren s Syndrome and Salivary Gland Dysfunction Cohorts and Healthy Volunteers Evaluating Oral Health Disparities as Determinants of Oral Health in a High-Risk Population
NCT03327870 ·Status: COMPLETED
-
Quality of Life and Sjögren Syndrome
NCT03578900 ·Status: COMPLETED ·Phase: PHASE4
-
An Evaluation of the Impact of a Single Dose of P-552 on Oral Mucosal Wetness
NCT01369589 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Natural History of Salivary Gland Dysfunction and Sjogren's Syndrome
NCT00001852 ·Status: COMPLETED
-
Evaluation of the Role of the Autonomic Nervous System in Sj(SqrRoot)(Delta)Gren s Syndrome
NCT00565526 ·Status: COMPLETED
-
The Pathogenesis and Natural History of Sjogren's Disease
NCT01425892 ·Status: RECRUITING
-
The Role of Central Sensitization on Biopsychosocial Factors in Primary Sjögren's Syndrome
NCT06410742 ·Status: COMPLETED
-
Efficacy of Cevimeline Versus Pilocarpine in the Secretion of Saliva
NCT01690052 ·Status: COMPLETED ·Phase: NA
-
A Clinical Study to Evaluate the Efficacy of Three Dry Mouth Relief Products Versus Water
NCT03494985 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Salivary Gland Dysfunction
NCT00001196 ·Status: TERMINATED
-
Dexamethasone Irrigation of the Parotid Glands in Primary Sjögren's Syndrome Subjects
NCT01316770 ·Status: TERMINATED ·Phase: PHASE2
-
Dental and Periodontal Status of Patients With Sjögren's Syndrome.
NCT04848870 ·Status: RECRUITING
-
OGT Spray in the Management of Xerostomia in the Elderly
NCT00350350 ·Status: COMPLETED
-
The Effect of Chewing Gum, Exercises of the Tongue, Lip, Jaw on Salivation, Xerostomia, Dysphagia in Sjögren's Syndrome
NCT05680064 ·Status: COMPLETED ·Phase: NA
-
Olfactory and Taste Disturbances in Sjogren's Syndrome
NCT04909112 ·Status: UNKNOWN ·Phase: NA
-
Salivary Evaluation in Healthy Volunteers
NCT00001390 ·Status: COMPLETED
-
Clinical Study New Gel for Xerostomia
NCT04184908 ·Status: UNKNOWN ·Phase: PHASE1
-
Symptoms of Frey's Syndrome
NCT05738395 ·Status: RECRUITING
-
Study of NGX267 Oral Capsules in Patients With Xerostomia Associated With Sjorgren's Syndrome
NCT00637793 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Oral Bacteria in Patients With Dry Mouth
NCT00048685 ·Status: COMPLETED
-
The Role of Xerostomia in Burning Mouth Syndrome: Case - Control Study
NCT01754740 ·Status: COMPLETED ·Phase: NA
-
A New Oral salIvary equivAlent Compared to Two moisturizinG Mouth sprAys in Patients With xeRostomiA: NIAGARA Study
NCT02049112 ·Status: COMPLETED ·Phase: PHASE4